P

Inventor

GROOTENHUIS PETER DIEDERIK JAN

US36 patents
⚠️ This page may combine multiple inventors who share the name “GROOTENHUIS PETER DIEDERIK JAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VERTEX PHARMA

24 patents
US9974781B2May 22, 2018

Modulators of ATP-binding cassette transporters

VERTEX PHARMA30 citations98
US9550761B2Jan 24, 2017

Modulators of ATP-binding cassette transporters

VERTEX PHARMA43 citations98
US9782408B2Oct 10, 2017

Modulators of cystic fibrosis transmembrane conductance regulator

VERTEX PHARMA33 citations97
US8952050B2Feb 10, 2015

Modulators of ATP-binding cassette transporters

VERTEX PHARMA62 citations97
US8952049B2Feb 10, 2015

Modulators of ATP-binding cassette transporters

VERTEX PHARMA62 citations97
US8796308B2Aug 5, 2014

Modulators of cystic fibrosis transmembrane conductance regulator

VERTEX PHARMA73 citations97
US8835639B2Sep 16, 2014

Process for making modulators of cystic fibrosis transmembrane conductance regulator

VERTEX PHARMA72 citations96
US10987348B2Apr 27, 2021

Modulators of ATP-binding cassette transporters

VERTEX PHARMA13 citations94
US10022352B2Jul 17, 2018

Modulators of ATP-binding cassette transporters

VERTEX PHARMA30 citations94
US10793547B2Oct 6, 2020

Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

VERTEX PHARMA24 citations93
US10758534B2Sep 1, 2020

Modulators of cystic fibrosis transmembrane conductance regulator

VERTEX PHARMA13 citations93
US10258624B2Apr 16, 2019

Modulators of cystic fibrosis transmembrane conductance regulator

VERTEX PHARMA32 citations93
US9511067B2Dec 6, 2016

Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels

VERTEX PHARMA17 citations92
US7678802B2Mar 16, 2010

Quinazolines useful as modulators of ion channels

VERTEX PHARMA16 citations89
US11426407B2Aug 30, 2022

Modulators of cystic fibrosis transmembrane conductance regulator

VERTEX PHARMA6 citations85
US11453655B2Sep 27, 2022

Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

VERTEX PHARMA8 citations84
US11414439B2Aug 16, 2022

Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

VERTEX PHARMA6 citations74
US12168009B2Dec 17, 2024

Modulators of cystic fibrosis transmembrane conductance regulator

VERTEX PHARMA1 citations72
US10738030B2Aug 11, 2020

Modulators of cystic fibrosis transmembrane conductance regulator

VERTEX PHARMA6 citations71
US8343763B2Jan 1, 2013

Heterocyclic derivatives as modulators of ion channels

VERTEX PHARMA2 citations62
US12384762B2Aug 12, 2025

Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

VERTEX PHARMA0 citations61
US9181273B2Nov 10, 2015

Morpholine-spirocyclic piperidine amides as modulators of ion channels

VERTEX PHARMA0 citations51
US12269831B2Apr 8, 2025

Modulators of cystic fibrosis transmembrane conductance regulator

VERTEX PHARMA0 citations48
US10233191B2Mar 19, 2019

Fused piperidine amides as modulators of ion channels

VERTEX PHARMA0 citations39

HADIDA-RUAH SARA SABINA

5 patents

YANG XIAOQING

1 patent

MILLER MARK THOMAS

1 patent

SHETH URVI

1 patent

UNIV GLASGOW

1 patent

AKZO NOBEL NV

1 patent

HADIDA RUAH SARA SABINA

1 patent

HILGRAF NICOLE

1 patent